The page is the record's research on the issuer — no analyst, no rating, no view. # SAB Biotherapeutics, Inc. (NASDAQ: SABS) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is SAB Biotherapeutics, Inc., listed on NASDAQ under ticker SABS, with ISIN US78397T2024. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 65 filings across 39 filing days in the window 2025-11-08 to 2026-11-08. The median gap between filing days is 6.0 days. The latest filing is dated 2026-11-05, 3 days before the record date of 2026-11-08, and is a results filing. The exchange median for NASDAQ is 52 filings, a cadence gap of 6.0 days, and a latency of 5.0 days. The sector median for 2836 Biological Products, (No Diagnostic Substances) is 65.5 filings, a cadence gap of 5.5 days, and a latency of 4.0 days. ## Auditor The auditor of record is EisnerAmper L.L.P., located in Iselin, New Jersey. The record holds no auditor changes. ## Events and halts The record holds one delisting line, dated 2026-10-22. It holds no listing, name change or segment move lines. A domicile change is not on the record. The issuer is listed and not halted, and the record holds one halt_suspension filing in the window. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations page. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001833214.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/SABS (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/SABS (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/SABS · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp